ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market

ALZAI Health Corp. Posted for Trading On The Frankfurt Stock Exchange

ALZAI Health Corp. Announces Marketing Services Agreement

ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment

ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology

ALZAI HEALTH CORP. ANNOUNCES VALIDATION OF ITS AI-DRIVEN ALZHEIMERS DISEASE RISK SCREENING SOLUTION ON LARGE-SCALE U.S. PATIENT DATA